## NOC: Northrop Grumman Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -5.2% below STRENGTH zone (3.0-6.0%); PEG 3.57 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($524.79)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. 3 Reasons to Sell NOC and 1 Stock to Buy Instead**
- Source: Finviz | 20251202T110500 | Neutral | Relevance: 99%
- This article identifies three reasons to consider selling Northrop Grumman (NOC) stock: slow organic growth suggesting waning demand, shrinking operating margins over the past five years, and declining return on invested capital (ROIC) indicating less profitable new investments. The author suggests opportunities elsewhere due to a high forward P/E and recommends looking into semiconductor stocks or StockStory's curated list of high-quality stocks.

**2. Is Northrop Grumman Stock Outperforming the Dow?**
- Source: Markets Financial Content | 20251201T020500 | Neutral | Relevance: 98%
- Northrop Grumman (NOC) stock performance is analyzed relative to the Dow Jones Industrial Average ($DOWI). Despite a recent decline from its 52-week high and mixed Q3 earnings, NOC has outperformed the Dow over the past three months, year-to-date, and over the past 52 weeks. The article notes the company's large market cap and critical role in defense and aerospace, and it highlights an analyst consensus of "Moderate Buy" for the stock.

**3. BNP Paribas Has a Positive Outlook on Northrop Grumman (NOC)**
- Source: Insider Monkey | 20251202T013300 | Bullish | Relevance: 98%
- BNP Paribas initiated coverage on Northrop Grumman (NOC) with an Outperform rating and a $710 price target, highlighting it as a top industrial stock. This positive outlook is further supported by Northrop Grumman securing a $100 million contract from the U.S. Air Force for support services related to its Stand-in Attack Weapon (SiAW) Subsystem. The company, a Virginia-based global aerospace and defense firm, will perform the contracted tasks in Baltimore, Maryland, utilizing its advanced sensing and seeker manufacturing sites.

**4. BNP Paribas Has a Positive Outlook on Northrop Grumman (NOC)**
- Source: Finviz | 20251202T013300 | Bullish | Relevance: 97%
- BNP Paribas Exane initiated coverage of Northrop Grumman (NOC) with an Outperform rating and a $710 price target. This positive analyst outlook is supported by Northrop Grumman securing a significant contract valued at up to $100 million from the United States Air Force for support services related to its Stand-in Attack Weapon (SiAW) Subsystem. The contract runs until December 2034, reinforcing the company's long-term prospects in the defense sector.

**5. Mackenzie Financial Corp Purchases 6,307 Shares of Northrop Grumman Corporation $NOC**
- Source: MarketBeat | 20251201T122053 | Somewhat-Bullish | Relevance: 97%
- Mackenzie Financial Corp increased its stake in Northrop Grumman Corporation by 4.0% in Q2, acquiring an additional 6,307 shares to hold a total of 165,507 shares valued at approximately $82.75 million. Other institutional investors also modified their holdings of Northrop Grumman, which recently beat Q3 earnings estimates and announced a quarterly dividend of $2.31 per share. Wall Street analysts have issued a "Moderate Buy" consensus rating for the company with an average price target of $646.94.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($0.08M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.5% (+0.8%)
- State Street Corpora: 9.3% (-1.6%)
- Capital Internationa: 8.2% (-1.7%)
- Blackrock Inc.: 6.9% (+1.0%)
- JPMORGAN CHASE & CO: 3.9% (+91.5%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-4.8% 5d) with bearish MACD, trend may be turning.
2. Valuation stretched: PEG 3.6x requires aggressive growth execution.
3. Near-term weakness: 6.9% below SMA50 despite long-term uptrend.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.57 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 26%). Balance sheet: $1.3B free cash flow. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $79.5B |
| Beta | 0.05 |
| 52W Range | $426.24 - $640.90 |
| Short Interest | 1.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.57 |
| Forward P/E | 19.0 |
| Current P/E | 21.0 |
| YoY Growth | 10.6% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -0.4% to -5.2% (-4.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.2pp (needs >3.0% for momentum thesis). Underperforming sector by 4.0pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.02x) but short-term weakness (below SMA20).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -5.20% (CS: 4) | Weak |
| RSI_14 | 32.8 | Neutral |
| MACD Histogram | -0.47 | Bearish |
| vs SMA20 | 0.969x | Below |
| vs SMA50 | 0.931x | Below |
| vs SMA200 | 1.023x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $546.97
- **Stop Loss:** $524.79 (4.1% risk)
- **Target:** $569.15 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 22
- **Position Value:** $12,033.34
- **Portfolio %:** 12.03%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-01-29 (Est: $6.95)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.46 | $7.67 | +18.8% |
| 2025Q2 | $6.80 | $8.15 | +19.9% |
| 2025Q1 | $6.26 | $3.32 | -47.0% |
| 2024Q4 | $6.35 | $6.39 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*